| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	Cowen & Co. analyst Joshua Jennings downgrades Apollo Endosurgery (NASDAQ:APEN) from Outperform to Market Perform and lo...
 
																	Apollo Endosurgery's (NASDAQ:APEN) short percent of float has fallen 63.08% since its last report. The company recently rep...
 
																	
 
																	Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.
 
																	A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The...
 
																	Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointe...
 
																	
